Catalyst Pharmaceuticals, Inc. (CPRX)
25.88
+0.02
(+0.10%)
USD |
NASDAQ |
Apr 16, 16:00
25.88
0.00 (0.00%)
After-Hours: 16:28
Catalyst Pharmaceuticals Research and Development Expense (Quarterly) : 1.807M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 1.376M |
| ANI Pharmaceuticals, Inc. | 12.26M |
| Indivior Pharmaceuticals, Inc. | 17.00M |
| Inovio Pharmaceuticals, Inc. | 9.921M |
| United Therapeutics Corp. | 139.50M |